Tag: richard admani
Prodigy responds to FDA warning
September 5, 2013HME News Staff
CHARLOTTE, N.C. - Prodigy Diabetes Care has conducted a regulatory assessment by an independent auditor to examine, review and revise certain procedures and training to ensure compliance with FDA requirements, it told patients, caregivers and partners in a Sept. 4 letter.
“Prodigy assures you that this attention to improvement is an ongoing effort to ensure full compliance,” stated CEO Richard Admani in the letter.
In a Feb. 22 letter, the FDA warned Prodigy about numerous violations,...
Blood Glucose Monitor, Diabetes, richard admani
Sponsored Stories
SOS Achieves Remarkable 400% Growth in 2023, Bolsters Team with Director Appointment
By Strategic Office SupportCyber Siege: The Financial Vulnerability Healthcare Didn't See Coming
By Strategic Office SupportA new staffing model that delivers ready-to-work pros, boosting efficiency and lowering costs.
By Tactical Back Office
By John Koch, COO and co-founder, MediStreams